The global fibromyalgia treatment market is projected for continued growth, with a market size expected to reach USD 4.51 billion by 2031. This translates to a compound annual growth rate (CAGR) of 3.9% during the forecast period of 2024-2031, according to a recent market analysis. While the growth may be moderate, the market demonstrates resilience amidst potential economic...

The global central nervous system treatment market is on track for remarkable expansion, with a projected value of USD 196.53 billion by 2030. This translates to a compelling compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023-2030, according to a recent market analysis. The market size was valued at USD 97.20 billion in 2022. Key Players The major key...